The contract concerns supplies of the pharmaceutical specialty containing the active substance “Infliximab” as a solution for infusion to be diluted (powder) and administered intravenously. The pharmaceutical specialty is supplied in a bottle containing 100 mg of active ingredient.

The contract concerns supplies of the pharmaceutical specialty containing the active substance “Infliximab” as a solution for infusion to be diluted (powder) and administered intravenously. The pharmaceutical specialty is supplied in a bottle containing 100 mg of active ingredient.